SSI Investment Management’s Allergan plc AGN.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-19,733
Closed -$11.6M 324
2017
Q4
$11.6M Sell
19,733
-16,106
-45% -$10.4M 0.97% 22
2017
Q3
$26.4M Buy
35,839
+440
+1% +$365K 2.26% 4
2017
Q2
$30.7M Buy
35,399
+868
+3% +$727K 2.7% 2
2017
Q1
$29.2M Buy
34,531
+1,023
+3% +$848K 2.68% 4
2016
Q4
$25.5M Buy
33,508
+711
+2% +$537K 2.34% 4
2016
Q3
$26.9M Buy
32,797
+366
+1% +$316K 2.38% 4
2016
Q2
$27M Buy
32,431
+3,296
+11% +$2.75M 2.58% 4
2016
Q1
$26.7M Buy
29,135
+39
+0.1% +$37.3K 2.74% 3
2015
Q4
$29.8M Buy
29,096
+1,113
+4% +$1.12M 3.05% 2
2015
Q3
$26.5M Sell
27,983
-1,630
-6% -$1.7M 2.85% 1
2015
Q2
$30.9M Buy
+29,613
New +$31M 3.03% 2

Other funds holding AGN.PRA

SSI Investment Management's AGN.PRA Position: Q1 2018 in Review

SSI Investment Management sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 19,733 shares — an estimated $11.6M sold.

SSI Investment Management first reported a position in AGN.PRA in Q2 2015 and held it in 11 quarters. The position peaked at $30.9M in Q2 2015. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

  • SSI Investment Management reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • SSI Investment Management sold 19,733 Allergan plc shares in Q1 2018, an estimated $11.6M.
  • SSI Investment Management first reported a position in Allergan plc in Q2 2015 and held it in 11 quarters.
  • SSI Investment Management's Allergan plc position peaked at $30.9M in Q2 2015.
  • 1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on SSI Investment Management's 13F filing for Q1 2018, filed 14 May 2018.